BR9301944A - Derivado de proteina c,molecula de dna recombinante,celula hospedeira e formulacao farmaceutica - Google Patents
Derivado de proteina c,molecula de dna recombinante,celula hospedeira e formulacao farmaceuticaInfo
- Publication number
- BR9301944A BR9301944A BR9301944A BR9301944A BR9301944A BR 9301944 A BR9301944 A BR 9301944A BR 9301944 A BR9301944 A BR 9301944A BR 9301944 A BR9301944 A BR 9301944A BR 9301944 A BR9301944 A BR 9301944A
- Authority
- BR
- Brazil
- Prior art keywords
- protein
- derivative
- host cell
- recombinant dna
- dna molecule
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6464—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88719192A | 1992-05-21 | 1992-05-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9301944A true BR9301944A (pt) | 1993-11-30 |
Family
ID=25390640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9301944A BR9301944A (pt) | 1992-05-21 | 1993-05-20 | Derivado de proteina c,molecula de dna recombinante,celula hospedeira e formulacao farmaceutica |
Country Status (23)
Country | Link |
---|---|
US (1) | US5453373A (pt) |
EP (1) | EP0575054B1 (pt) |
JP (1) | JP3564150B2 (pt) |
KR (1) | KR100291529B1 (pt) |
CN (1) | CN1080658A (pt) |
AT (1) | ATE286121T1 (pt) |
AU (1) | AU661901B2 (pt) |
BR (1) | BR9301944A (pt) |
CA (1) | CA2096604C (pt) |
CZ (1) | CZ286016B6 (pt) |
DE (1) | DE69333727T2 (pt) |
DK (1) | DK0575054T3 (pt) |
ES (1) | ES2233925T3 (pt) |
FI (1) | FI932282A (pt) |
HU (1) | HU218408B (pt) |
IL (1) | IL105757A0 (pt) |
MX (1) | MX9302917A (pt) |
MY (1) | MY110664A (pt) |
NO (1) | NO311299B1 (pt) |
NZ (1) | NZ247651A (pt) |
PH (1) | PH29911A (pt) |
PT (1) | PT575054E (pt) |
RU (1) | RU2122004C1 (pt) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2067525C (en) * | 1991-05-09 | 1998-09-15 | Helmut G. Alt | Organometallic fluorenyl compounds, preparation and use |
AT402262B (de) * | 1991-06-20 | 1997-03-25 | Immuno Ag | Arzneimittel enthaltend aktiviertes protein c |
WO1993007491A1 (en) * | 1991-10-04 | 1993-04-15 | Board Of Regents Of The University Of Nebraska | A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins |
US5716795A (en) * | 1991-10-04 | 1998-02-10 | Matschiner; John T. | Thrombomodulin-based coagulometric assay of the protein C system |
DE4320294A1 (de) * | 1993-06-18 | 1994-12-22 | Immuno Ag | Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen |
EA002149B1 (ru) | 1997-04-28 | 2001-12-24 | Эли Лилли Энд Компани | Улучшенные способы приготовления активированного белка с |
US6630137B1 (en) * | 1997-04-28 | 2003-10-07 | Eli Lilly And Company | Activated protein C formulations |
WO1998055142A1 (en) * | 1997-06-05 | 1998-12-10 | Eli Lilly And Company | Methods for treating thrombotic disorders |
HUP0001237A3 (en) * | 1997-10-20 | 2002-01-28 | Lilly Co Eli | Methods for treating vascular disorders |
EP1140121A4 (en) * | 1998-07-31 | 2004-07-14 | Lilly Co Eli | CRYOGRANULATION OF ACTIVATED PROTEIN C |
US6815533B1 (en) | 1998-07-31 | 2004-11-09 | Eli Lilly And Company | Cryogranulation of activated protein C |
EP1124573A1 (en) | 1998-10-22 | 2001-08-22 | Eli Lilly And Company | Methods for treating sepsis |
EP1128842B1 (en) | 1998-11-13 | 2006-03-15 | Eli Lilly And Company | Use of human protein c for the manufacture of a medicament for treating heparin-induced thrombocytopenia |
DE69906568T2 (de) | 1998-11-20 | 2004-02-12 | Eli Lilly And Co., Indianapolis | Behandlung von hämorrhagischem virusfieber mit protein c |
DK1133314T3 (da) | 1998-11-23 | 2003-04-14 | Lilly Co Eli | Protein C til behandling af seglcellesygdom og thalassæmi |
US6998122B1 (en) * | 1999-04-30 | 2006-02-14 | Eli Lilly And Company | Protein C derivatives |
JP2003514545A (ja) * | 1999-11-19 | 2003-04-22 | イーライ・リリー・アンド・カンパニー | プロテインc誘導体 |
ES2234807T3 (es) * | 2000-02-02 | 2005-07-01 | Eli Lilly And Company | Derivados de proteina c. |
EP1263943A1 (en) | 2000-02-11 | 2002-12-11 | Eli Lilly & Company | Protein c derivatives |
US7204981B2 (en) * | 2000-03-28 | 2007-04-17 | Eli Lilly And Company | Methods of treating diseases with activated protein C |
CN100392079C (zh) * | 2000-10-18 | 2008-06-04 | 马克西根公司 | 蛋白c或活化的蛋白c-样分子 |
JP4071105B2 (ja) * | 2000-10-18 | 2008-04-02 | マキシゲン・エイピーエス | プロテインcまたは活性化プロテインc様分子 |
US6933367B2 (en) | 2000-10-18 | 2005-08-23 | Maxygen Aps | Protein C or activated protein C-like molecules |
US20040198652A1 (en) * | 2001-04-24 | 2004-10-07 | Carter J. Paul | Methods and compositions for preventing and treating septic shock and endotoxemia |
EP1485121A4 (en) * | 2002-03-08 | 2007-11-07 | Lilly Co Eli | ACTIVE C PROTEIN FORMULATIONS |
WO2003106666A2 (en) * | 2002-06-14 | 2003-12-24 | Maxygen Aps | Protein c variants with altered properties |
US20070142272A1 (en) * | 2003-01-24 | 2007-06-21 | Zlokovic Berislav V | Neuroprotective activity of activated protein c independent of its anticoagulant activity |
WO2006014839A2 (en) * | 2004-07-23 | 2006-02-09 | The University Of Rochester | Activated protein c inhibits undesirable effects of plasminogen activator in the brain |
WO2006136033A1 (en) * | 2005-06-23 | 2006-12-28 | The University Of British Columbia | Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy |
EP2041338A4 (en) * | 2006-06-09 | 2009-09-30 | Univ British Columbia | INTERFERON GAMMA POLYMORPHISMS AS INDICATORS OF PATIENT RESULTS IN FATIGUE PATIENTS |
EP2178556B1 (en) * | 2007-06-18 | 2011-08-17 | Oregon Health & Science University | Protein c for use in maintaining hemostasis |
EP2242875A4 (en) * | 2008-01-15 | 2012-04-04 | Univ British Columbia | PROTEIN C RS2069915 AS A SURVIVOR RESPONSE PREDICTOR AND ADMINISTRATION OF PROTEIN C OR AN ACTIVE PROTEIN C COMPOUND |
WO2010070137A1 (en) | 2008-12-19 | 2010-06-24 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders |
WO2012068519A2 (en) | 2010-11-19 | 2012-05-24 | Sirius Genomics Inc. | Markers associated with response to activated protein c administration, and uses thereof |
CN104394883B (zh) | 2012-07-04 | 2017-05-31 | 悉尼大学 | 炎性皮肤病症的治疗 |
CA2946028C (en) | 2014-04-16 | 2022-10-11 | Zz Biotech Llc | Treatment of abnormal cutaneous scarring |
WO2023119230A1 (en) | 2021-12-22 | 2023-06-29 | L'oreal | Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4775624A (en) * | 1985-02-08 | 1988-10-04 | Eli Lilly And Company | Vectors and compounds for expression of human protein C |
US4992373A (en) * | 1987-12-04 | 1991-02-12 | Eli Lilly And Company | Vectors and compounds for direct expression of activated human protein C |
ZA889497B (en) * | 1987-12-28 | 1990-08-29 | Lilly Co Eli | Vectors and compounds for expression of zymogen forms of human protein c |
US4981952A (en) * | 1988-10-04 | 1991-01-01 | Eli Lilly And Company | Method for the purification of vitamin K-dependent proteins |
IL97311A0 (en) * | 1990-02-23 | 1992-05-25 | Lilly Co Eli | Vectors and compounds for expression of glycosylation mutants of human protein c |
US5270178A (en) * | 1990-02-23 | 1993-12-14 | Eli Lilly And Company | Vectors and compounds for expression of zymogen forms of human protein C |
-
1993
- 1993-05-18 MY MYPI93000913A patent/MY110664A/en unknown
- 1993-05-19 CZ CZ93948A patent/CZ286016B6/cs not_active IP Right Cessation
- 1993-05-19 DE DE69333727T patent/DE69333727T2/de not_active Expired - Fee Related
- 1993-05-19 RU RU93005089A patent/RU2122004C1/ru active
- 1993-05-19 FI FI932282A patent/FI932282A/fi unknown
- 1993-05-19 KR KR1019930008613A patent/KR100291529B1/ko not_active IP Right Cessation
- 1993-05-19 ES ES93303894T patent/ES2233925T3/es not_active Expired - Lifetime
- 1993-05-19 PT PT93303894T patent/PT575054E/pt unknown
- 1993-05-19 CA CA002096604A patent/CA2096604C/en not_active Expired - Fee Related
- 1993-05-19 HU HU9301461A patent/HU218408B/hu not_active IP Right Cessation
- 1993-05-19 EP EP93303894A patent/EP0575054B1/en not_active Expired - Lifetime
- 1993-05-19 NO NO19931840A patent/NO311299B1/no not_active IP Right Cessation
- 1993-05-19 DK DK93303894T patent/DK0575054T3/da active
- 1993-05-19 MX MX9302917A patent/MX9302917A/es unknown
- 1993-05-19 AT AT93303894T patent/ATE286121T1/de not_active IP Right Cessation
- 1993-05-19 NZ NZ247651A patent/NZ247651A/en unknown
- 1993-05-20 AU AU38699/93A patent/AU661901B2/en not_active Ceased
- 1993-05-20 JP JP11822393A patent/JP3564150B2/ja not_active Expired - Fee Related
- 1993-05-20 PH PH46212A patent/PH29911A/en unknown
- 1993-05-20 BR BR9301944A patent/BR9301944A/pt not_active Application Discontinuation
- 1993-05-20 CN CN93106214A patent/CN1080658A/zh active Pending
- 1993-05-20 IL IL105757A patent/IL105757A0/xx unknown
- 1993-07-09 US US08/089,215 patent/US5453373A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HU218408B (hu) | 2000-08-28 |
FI932282A0 (fi) | 1993-05-19 |
IL105757A0 (en) | 1993-09-22 |
PH29911A (en) | 1996-09-16 |
RU2122004C1 (ru) | 1998-11-20 |
DE69333727D1 (de) | 2005-02-03 |
DK0575054T3 (da) | 2005-04-25 |
ATE286121T1 (de) | 2005-01-15 |
CZ286016B6 (cs) | 1999-12-15 |
ES2233925T3 (es) | 2005-06-16 |
EP0575054A2 (en) | 1993-12-22 |
FI932282A (fi) | 1993-11-22 |
KR100291529B1 (ko) | 2001-06-01 |
NO931840L (no) | 1993-11-22 |
AU661901B2 (en) | 1995-08-10 |
EP0575054A3 (en) | 1995-04-19 |
PT575054E (pt) | 2005-03-31 |
US5453373A (en) | 1995-09-26 |
NZ247651A (en) | 1995-03-28 |
CZ94893A3 (en) | 1994-01-19 |
CA2096604A1 (en) | 1993-11-22 |
MX9302917A (es) | 1993-11-01 |
HUT69615A (en) | 1995-09-28 |
EP0575054B1 (en) | 2004-12-29 |
NO931840D0 (no) | 1993-05-19 |
KR930023370A (ko) | 1993-12-18 |
DE69333727T2 (de) | 2005-12-15 |
CA2096604C (en) | 2003-12-16 |
JP3564150B2 (ja) | 2004-09-08 |
AU3869993A (en) | 1993-11-25 |
MY110664A (en) | 1999-01-30 |
CN1080658A (zh) | 1994-01-12 |
NO311299B1 (no) | 2001-11-12 |
HU9301461D0 (en) | 1993-09-28 |
JPH0680698A (ja) | 1994-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9301944A (pt) | Derivado de proteina c,molecula de dna recombinante,celula hospedeira e formulacao farmaceutica | |
NO900770D0 (no) | Produksjon av glykoseoksidase i rekombinante systemer. | |
RU93005089A (ru) | Производное белка с человека, днк, клетка, фармацевтическая композиция, применение производного белка с, способ получения | |
ES2132066T3 (es) | Procedimiento para la produccion de proteina biologicamente activa (v.g. tfg). | |
DE69131580D1 (de) | GDF-1 und UOG1 Proteine | |
DE69132545D1 (de) | Protein mit Cytokinaktivität, Rekombinant-DNS, Expressionsvektor und Wirtszellen zu seiner Herstellung | |
ES2101716T3 (es) | Vectores y compuestos para la expresion de mutantes de glicosilacion de la proteina c humana. | |
DE68917837D1 (de) | Peptid-Verbindungen. | |
DE69033756D1 (de) | Gene, die für MACIF Proteine kodieren, Expressionsvektoren mit diesem Genen, und Transformantenzellen mit diesem Proteinen | |
DE69636714D1 (de) | G-CSF TPO Fusionsproteine | |
PT88539A (pt) | Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen | |
IT1262954B (it) | Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi. | |
TR200002611T2 (tr) | Beta-lipotropin ve kullanımları | |
ES2129022T3 (es) | Proteina condromodulina-i. | |
ATA166890A (de) | Rekombinantes dna-molekül für allergene des erlenpollens, damit hergestellte proteine bzw. polypeptide, sowie deren anwendung | |
MX24651A (es) | Compuestos de adn recombinante, vectores de expresion de mutantes de glicosilacion de la proteina c humana, celulas huesped transformadas y metodo para la produccion recombinante de formas zimogenas de proteina c humana. | |
YU34793A (sh) | Derivati proteina c |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EE | Request for examination | ||
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
FC | Decision: refusal | ||
FC | Decision: refusal | ||
CKFC | Appeal: appeal against refusal | ||
B15K | Others concerning applications: alteration of classification |
Ipc: C12N 9/64 (2006.01), A61K 38/00 (2006.0 |